Anthocyanins, as natural bioactive compounds, hold significant promise in managing obesity and related metabolic disorders through their modulation of the PI3K/Akt signaling pathway and its downstream targets, such as GLUT4, FOXO, GSK3β, and mTOR. The gene discussed is SLC2A4; the disease is Other metabolic disease.